Latest research
Latest corporate research
Latest tax enhanced research
Subscribe now
What we do
Corporate research services
Tax enhanced research services
Bespoke consulting services
About Hardman & Co.
Case Studies
News & events
Contact us
Twitter icon
Created with Sketch.
Latest corporate research
Detailed company analysis created specifically for investors
Latest tax enhanced research
Product reports for investors and advisors
Subscribe now
Receive our latest research as soon as it is published
Corporate Research & Analysis
Detailed company analysis created for specifically for investors
Tax Enhanced Services
Product reports for investors and advisors
Bespoke Services
Services for clients with specific needs
About Hardman & Co.
We are the longest-established commissioned research provider. Read our story
Case Studies
We help a wide range of clients with different needs. Read what they say about us
Latest Update
Our research can still be accessed for free under MIFID II.
Find out more >
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Life Sciences
Media
Mining
Oil & Gas
Property
Services
Technology
Utilities
list companies
Primary Health Properties
Property
Growing the footprint; optimising income and NAV
By
Mike Foster
29 Oct 2018
Volta Finance
Financials
Volta Finance October Monthly
By
Mark Thomas
03 Oct 2018
Stay up-to-date with the latest research
Sign up to our newsletter
Allergy Therapeutics plc
Life Sciences
2018 full-year results: solid growth
By
Dr Martin Hall
27 Sep 2018
Oxford BioMedica
Life Sciences
Partnering strategy delivering profitability
By
Dr Dorothea Hill
20 Sep 2018
City of London Investment Group
Financials
Strengthening cash position to boost returns
By
Dr Brian Moretta
20 Sep 2018
DP Poland Plc
Consumer
Initiation: Fully proven model rolls out
By
Jason Streets
18 Sep 2018
Tissue Regenix
Life Sciences
Strategy delivering growth above expectations
By
Dr Martin Hall
14 Sep 2018
Redx Pharma
Life Sciences
Back to the clinic
By
Dr Dorothea Hill
06 Sep 2018
Avacta Group plc
Life Sciences
Capital increase for further development
By
Dr Martin Hall
05 Sep 2018
Bionomics Ltd
Life Sciences
FY’18 – focus on PTSD drug development
By
Dr Martin Hall
03 Sep 2018
Advanced Oncotherapy
Life Sciences
Treatment planning system agreement
By
Dr Martin Hall
29 Aug 2018
1
2
3
...
12
Next